<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Drieux F</dc:creator>
  <dc:creator>Ruminy P</dc:creator>
  <dc:creator>Abdel-Sater A</dc:creator>
  <dc:creator>Lemonnier F</dc:creator>
  <dc:creator>Viailly PJ</dc:creator>
  <dc:creator>Fataccioli V</dc:creator>
  <dc:creator>Marchand V</dc:creator>
  <dc:creator>Bisig B</dc:creator>
  <dc:creator>Letourneau A</dc:creator>
  <dc:creator>Parrens M</dc:creator>
  <dc:creator>Bossard C</dc:creator>
  <dc:creator>Bruneau J</dc:creator>
  <dc:creator>Dobay P</dc:creator>
  <dc:creator>Veresezan L</dc:creator>
  <dc:creator>Dupuy A</dc:creator>
  <dc:creator>Pujals A</dc:creator>
  <dc:creator>Robe C</dc:creator>
  <dc:creator>Sako N</dc:creator>
  <dc:creator>Copie-Bergman C</dc:creator>
  <dc:creator>Delfau-Larue MH</dc:creator>
  <dc:creator>Picquenot JM</dc:creator>
  <dc:creator>Tilly H</dc:creator>
  <dc:creator>Delarue R</dc:creator>
  <dc:creator>Jardin F</dc:creator>
  <dc:creator>de Leval L</dc:creator>
  <dc:creator>Gaulard P</dc:creator>
  <dc:date>2020</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Peripheral T-cell lymphoma comprises a heterogeneous group of mature non-Hodgkin lymphomas. Their diagnosis is challenging, with up to 30% of cases remaining unclassifiable and referred to as "not otherwise specified". We developed a reverse transcriptase-multiplex ligation-dependent probe amplification gene expression profiling assay to differentiate the main T-cell lymphoma entities and to study the heterogeneity of the "not specified" category. The test evaluates the expression of 20 genes, including 17 markers relevant to T-cell immunology and lymphoma biopathology, one Epstein-Barr virus-related transcript, and variants of RHOA (G17V) and IDH2 (R172K/T). By unsupervised hierarchical clustering, our assay accurately identified 21 of 21 ALK-positive anaplastic large cell lymphomas, 16 of 16 extranodal natural killer (NK)/T-cell lymphomas, 6 of 6 hepatosplenic T-cell lymphomas, and 13 of 13 adult T-cell leukemia/lymphomas. ALK-negative anaplastic lymphomas (n=34) segregated into one cytotoxic cluster (n=10) and one non-cytotoxic cluster expressing Th2 markers (n=24) and enriched in DUSP22-rearranged cases. The 63 TFH-derived lymphomas divided into two subgroups according to a predominant TFH (n=50) or an enrichment in Th2 (n=13) signatures. We next developed a support vector machine predictor which attributed a molecular class to 27 of 77 not specified T-cell lymphomas: 17 TFH, five cytotoxic ALK-negative anaplastic and five NK/T-cell lymphomas. Among the remaining cases, we identified two cell-of-origin subgroups corresponding to cytotoxic/Th1 (n=19) and Th2 (n=24) signatures. A reproducibility test on 40 cases yielded a 90% concordance between three independent laboratories. This study demonstrates the applicability of a simple gene expression assay for the classification of peripheral T-cell lymphomas. Its applicability to routinely-fixed samples makes it an attractive adjunct in diagnostic practice.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/278246</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2019.226647</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/31488561</dc:relation>
  <dc:source>Haematologica. - 2020</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Hematology</dc:subject>
  <dc:title xmlns:ns2="xml" ns2:lang="en">Defining signatures of peripheral T-cell lymphoma with a targeted 20-marker gene expression profiling assay.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
